48 results on '"Pintó X"'
Search Results
2. SEA 2022 standards for the comprehensive control of cardiovascular risk
3. Health-related quality of life in individuals with metabolic syndrome: A cross-sectional study
4. Nuevas perspectivas en el tratamiento de la hipercolesterolemia desde la disponibilidad de los inhibidores de la proteína PCSK9
5. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
6. Egg consumption and cardiovascular disease according to diabetic status: The PREDIMED study
7. Chronic kidney disease and dyslipidaemia
8. Atherogenic dyslipidemia: prevalence and management in lipid clinics
9. Dislipemia aterogénica: prevalencia y control en las unidades de lípidos
10. Fármacos establecidos para elevar el colesterol unido a lipoproteínas de alta densidad: ¿puede haber diferencias en los mecanismos y en los beneficios?
11. Clinical predictors of positive genetic testing in heterozygous familial hypercholesterolemia
12. Controversia terapéutica: clopidogrel y estatinas
13. Efectos inmunomoduladores de las estatinas
14. Importancia del colesterol ligado a lipoproteínas de alta densidad (cHDL) en la prevención del riesgo cardiovascular. Recomendaciones del Foro HDL
15. Efecto de diferentes polimorfismos en el gen del OATP-C sobre la respuesta hipolipemiante al tratamiento con pravastatina
16. Tratamiento de la dislipemia diabética con fármacos hipolipemiantes. Nuevos conceptos
17. Clinica e investigación en Arteriosclerosis, the Iberoamerican Journal of Lipidology and vascular risk
18. Clínica e Investigación en Arteriosclerosis, la revista Iberoamericana de lipidologia y riesgo vascular
19. Predictores de adhesión a tratamiento dietético: experiencia del PREDIMED
20. ¿Debe modificarse el tratamiento de la dislipidemia diabética después del estudio ACCORD?
21. Long-term effects of PCSK9I on lipid profile and goal attainment in high cardiovascular risk patients from a real-world clinical setting
22. Relationship between five genetic variants and the variability of hypertriglyceridemia
23. Mediterranean diet and heart rate: The PREDIMED randomised trial
24. PCV74 - COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK
25. Detection of Fabry disease in patients with premature cardiovascular disease
26. PCV43 - Epidemiological Burden and Management of Hypercholesterolemia in High Cardiovascular Risk Patients in Spain: a Comprehensive Picture from a Systematic Review of the Literature
27. Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio. Recomendaciones del foro HDL. Resumen ejecutivo
28. El largo trecho para llegar a los objetivos en el tratamiento de las dislipemias
29. Abstract: 129 UTILITY OF THE AUTOMATIC MEASUREMENT OF THE ARTERIAL PRESSURE AS SCREENING AND DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE
30. Mo-P6:456 Interactions between genetic variation of intestinal sterol absorption, serum sterols, and response to plant sterol in hypercholesterolemic patients
31. W05-P-005 Baseline levels of LDL-cholesterol and lipoprotein(A) and the Ava II polymorphism of the LDL receptor gene influence the response of LDL-cholesterol to pravastatin treatment
32. M.583 Ezetimibe added to ongoing statin therapy: Incremental reductions in low-density lipoprotein cholesterol are independent of statin efficacy
33. M.517 LDL-cholesterol goal attainment among patients treated with lipid lowering drugs in Spain
34. W14.382 Phenotypic expression of familial hypercholesterolemia associated with diabetes mellitus
35. The hospital de bellvitge atherosclerosis secondary preventive program. Main results and predictors of clinical course
36. A rare Apo E variant, Apo E3 ΔL149, associated with familial hypercholesterolemia
37. ApoE genotype does not predict cholesterol response to pravastatin in a large sample of ambulatory patients
38. An Enzyme-Linked Immunosorbent Assay Method to Measure Human Apolipoprotein E Levels Using Commercially Available Reagents: Effect of Apolipoprotein E Polymorphism on Serum Apolipoprotein E Concentration
39. Potentiels evoques somesthesiques (PES) et anesthesie totale intraveineuse sous propofol: Comparaison des effets de l'alfentanil et du sufentanil
40. 4.P.259 Disorders of lipoprotein metabolism in active sarcoidosis
41. Plasma Lp(a) values and severity of atherosclerotic disease in three vascular regions
42. 2.P.238 Moderate hyperhomocysteinemia and early myocardial infarction: Relation with vitamins B6, B12 and folate
43. 2.P.237 Cardiovascular risk factors in peripheral arterial disease patients with and without previous history of coronary artery disease
44. Identification of a novel mutation (Arg 99 → Cys) in the LCAT gene causing Fish Eye Disease in a Spanish family
45. The gemfibrozil atherosclerosis regression trial (Geart): a study to evaluate the effect of hypoalphalipoproteinemia treatment on the regression of coronary atherosclerosis
46. LDL oxidation differences in coronary patients classified according to HDL-cholesterol level
47. Cardiovascular risk factors in angina pectoris and myocardial infarction: sex differences
48. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.